AzTrials
AzTrials

Physical ActivityAIPDEUSNCT07825948

AI-Personalized Digital Exercise for University Students

A study testing AI-Personalized Digital Exercise Programme and Standardized Digital Exercise Programme in people with Physical Activity and Exercise Adherence, run by Transilvania University of Brasov at 1 site in Romania.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluated whether an AI-personalized digital exercise programme could improve exercise adherence, physical activity, wellbeing, and physical performance among university students compared with a standardized digital exercise programme. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Physical Activity, Exercise Adherence, Wellbeing
What is being tested?
AI-Personalized Digital Exercise Programme and Standardized Digital Exercise Programme
Could I receive a placebo?
No, everyone receives an active treatment
How many people
299 participants
Where
1 siteRomania
Study dates
24 Jan 2026to 21 Mar 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Undergraduate student currently enrolled at Transilvania University of Brașov. Age 18 to 65 years at baseline.
  • Written informed consent provided before any study-specific procedure.
  • Able to safely complete the standardized countermovement jump protocol using OptoJump.
  • Able to safely complete the lower-limb simple and choice reaction-time protocols using BlazePod.
  • Access to a smartphone compatible with the study application.
  • Willing to use the study application throughout the 8-week intervention.
  • Able to attend both baseline and post-intervention assessments.

Who cannot join

  • Acute musculoskeletal injury or pain that made jumping or rapid lower-limb responses unsafe.
  • Medical condition contraindicating exercise participation or study testing.
  • Use of medication known to affect neuromuscular performance or reaction time, as defined in the approved protocol.
  • Concurrent participation in another interventional exercise or digital-health trial.
  • Inability or unwillingness to complete the required assessments or the 8-week digital intervention.

Trial locations and contacts

1 site in 1 country.

Romania1 site
  • Transilvania University of Brașov

    Brasov, Brașov County, 500036

Other trials in Romania

About this study

Official title: Effects of an AI-Personalized Digital Exercise Programme on Adherence, Physical Activity, and Wellbeing Among University Students: An 8-Week Randomized Controlled Trial

This study evaluated whether an AI-personalized digital exercise programme could improve exercise adherence, physical activity, wellbeing, and physical performance among university students compared with a standardized digital exercise programme. University students were randomly assigned to one of two digital exercise programmes for 8 weeks. The AI-personalized programme adjusted exercise recommendations using participant characteristics, previous exercise adherence, readiness, pain, safety information, and physical performance measures. The comparator provided a standardized digital exercise programme without adaptive weekly personalization. The primary outcome was mean weekly exercise adherence. Secondary outcomes included physical activity, wellbeing, countermovement jump performance, lower-limb reaction time, engagement, usability, and safety.

Read the detailed description

This was an 8-week, two-group randomized controlled trial conducted among undergraduate students at Transilvania University of Brașov, Romania. The study compared an AI-personalized digital exercise programme with a standardized digital exercise programme delivered within the same digital study environment.

Participants assigned to the AI-personalized group received exercise recommendations through MoveAI-Student version 2.1.0 using the version-controlled v1.3-adaptive system. The system combined prespecified safety rules with a supervised recommendation model. Personalization used participant characteristics, sport participation, weekly training volume, countermovement jump performance, simple and choice reaction time, readiness, pain, previous-week adherence, and safety information. Exercise recommendations could specify session frequency, duration, intensity, and additional emphasis on lower-limb power or reactive drills. Recommendations were updated once per intervention week. Progression was limited by predefined safety rules, and exercise load could be reduced when pain or an adverse-event flag was present. Human override of recommendations was permitted when required.

Participants assigned to the standardized digital comparator used the same digital study environment but did not receive the adaptive weekly prescription procedure. The comparator programme prescribed three exercise sessions per week, with each session lasting 35 minutes.

The primary outcome was mean weekly exercise adherence, calculated from completed sessions relative to prescribed sessions across the 8-week intervention. Secondary outcomes included total physical activity assessed with the International Physical Activity Questionnaire Short Form, WHO-5 wellbeing, countermovement jump performance, simple reaction time, choice reaction time, moderate-to-vigorous physical activity, application engagement, satisfaction, perceived usefulness, usability, sitting time, body weight, body mass index, and adverse events.

The study was designed to estimate the effect of the adaptive programme as a complete intervention compared with standardized digital exercise. It was not designed to isolate the independent effect of the algorithm from differences in exercise prescription or completed exercise exposure.

Being tested
AI-Personalized Digital Exercise Programme, Standardized Digital Exercise Programme
Keywords
Artificial Intelligence, Digital Health, University Students, Exercise Adherence, Physical Activity, Personalized Exercise, Exercise Program, Wellbeing, Randomized Controlled Trial, Mobile Health
Medical subject headings
Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AI-Personalized Digital Exercise ProgrammeBehavioural

    An 8-week digital exercise intervention using MoveAI-Student version 2.1.0 and the v1.3-adaptive system. Initial exercise prescriptions ranged from three to five sessions per week, 30 to 45 minutes per session, at moderate-to-vigorous intensity. Recommendations were updated weekly using adherence and safety information. Prescriptions could modify session frequency, duration, intensity, and emphasis on lower-limb power or reactive drills. Predefined safety rules limited weekly progression and allowed reduced exercise load when pain or an adverse-event flag was present.

  • Standardized Digital Exercise ProgrammeBehavioural

    An 8-week standardized digital exercise intervention delivered through the same study application. Participants were prescribed three exercise sessions per week, with each session lasting 35 minutes. The programme did not use the adaptive weekly prescription procedure applied in the AI-personalized group.

Study groups in NCT07825948
Study groupRoleWhat they receive
AI-Personalized Digital Exercise ProgrammeExperimentalParticipants received an 8-week digital exercise programme delivered through MoveAI-Student version 2.1.0. Exercise prescriptions were personalized using the v1.3-adaptive system and updated weekly based on participant characteristics, previous-week adherence, readiness, pain, safety information, and physical performance measures. Recommendations could modify exercise frequency, duration, intensity, and task emphasis.
Receives: Behavioral: AI-Personalized Digital Exercise Programme
Standardized Digital Exercise ProgrammeActive comparatorParticipants received an 8-week standardized digital exercise programme through the same study application. The programme prescribed three exercise sessions per week, with each session lasting 35 minutes. Participants did not receive the adaptive weekly personalization procedure used in the experimental group.
Receives: Behavioral: Standardized Digital Exercise Programme

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Weekly Exercise Adherence

    Weekly adherence was calculated as completed exercise sessions relative to prescribed exercise sessions within each intervention week. The participant-level mean across the 8-week intervention was used as the primary outcome.

    Measured: From intervention initiation through the end of Week 8

Secondary outcomes (6)
  1. Total Physical Activity Assessed With the International Physical Activity Questionnaire-Short Form

    Total physical activity was assessed using the International Physical Activity Questionnaire-Short Form (IPAQ-SF) and expressed as metabolic equivalent of task (MET)-minutes per week. Total MET-minutes per week were calculated from reported walking, moderate-intensity activity, and vigorous-intensity activity. The minimum possible value is 0 MET-minutes/week. There is no fixed upper limit for this derived physical-activity measure. Higher values indicate a greater amount of total physical activity.

    Measured: Baseline and at the end of Week 8

  2. 5-item World Health Organization Well-Being Index (WHO-5) Score

    Well-being was assessed using the 5-item World Health Organization Well-Being Index (WHO-5). Each of the five items is scored from 0 to 5, producing a raw total score from 0 to 25. The raw score was multiplied by 4 to obtain the reported score ranging from 0 to 100. Higher scores indicate better subjective well-being.

    Measured: Baseline and at the end of Week 8

  3. Countermovement Jump Best Height

    Best countermovement jump height was assessed using OptoJump Next and expressed in centimeters.

    Measured: Baseline and at the end of Week 8

  4. Countermovement Jump Mean Height

    Mean countermovement jump height was assessed using OptoJump Next and expressed in centimeters.

    Measured: Baseline and at the end of Week 8

  5. Simple Reaction Time

    Description: Lower-limb simple reaction time was assessed using BlazePod and expressed in milliseconds.

    Measured: Baseline and at the end of Week 8

  6. Choice Reaction Time

    Lower-limb choice reaction time was assessed using BlazePod and expressed in milliseconds.

    Measured: Baseline and at the end of Week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2026
  2. Study start24 Jan 2026
  3. Primary completion21 Mar 2026
  4. Study completion21 Mar 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants were randomized after completion of baseline assessments to one of two parallel groups for 8 weeks: an AI-personalized digital exercise programme or a standardized digital exercise programme.
Masking
None (open label)
Enrolment
299 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07825948
Sponsor's protocol ID
FEFSM-411-2026-01
Acronym
AIPDEUS
Status last verified
Sep 2026
First submitted
12 Sep 2026
Last updated
22 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Deidentified individual participant data underlying the results reported in the published article will be available upon reasonable request. Shared data may include baseline characteristics, exercise adherence, physical activity, WHO-5 wellbeing, countermovement jump outcomes, simple and choice reaction time, engagement and usability measures, and adverse-event data, as applicable.

Questions about this trial

What is this clinical trial studying?

A study testing AI-Personalized Digital Exercise Programme and Standardized Digital Exercise Programme in people with Physical Activity and Exercise Adherence, run by Transilvania University of Brasov at 1 site in Romania.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Romania. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Weekly Exercise Adherence (time frame: From intervention initiation through the end of Week 8). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in